Fsd Pharma Class Stock Buy Hold or Sell Recommendation
| HUGE Stock | USD 0.46 0 0.22% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding FSD Pharma Class is 'Strong Sell'. Macroaxis provides FSD Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HUGE positions. The advice algorithm takes into account all of FSD Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting FSD Pharma's buy or sell advice are summarized below:
Real Value 0.44 | Hype Value 0.44 | Market Value 0.46 | Naive Value 0.35 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell FSD Pharma Class given historical horizon and risk tolerance towards FSD Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for FSD Pharma Class, the advice is generated through an automated system that utilizes algorithms and statistical models.
FSD |
Execute FSD Pharma Buy or Sell Advice
The FSD recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on FSD Pharma Class. Macroaxis does not own or have any residual interests in FSD Pharma Class or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute FSD Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
FSD Pharma Trading Alerts and Improvement Suggestions
| FSD Pharma Class generated a negative expected return over the last 90 days | |
| FSD Pharma Class has some characteristics of a very speculative penny stock | |
| FSD Pharma Class has high historical volatility and very poor performance | |
| Net Loss for the year was (18.56 M) with loss before overhead, payroll, taxes, and interest of (3.33 M). | |
| FSD Pharma Class currently holds about 31.62 M in cash with (11.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.83, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| FSD Pharma Class has a frail financial position based on the latest SEC disclosures | |
| Roughly 17.0% of the company shares are held by company insiders | |
| Latest headline from techtimes.com: Sky Rolls Out Huge Upgrades For TV Viewers that Football Fans Will Surely Love |
FSD Pharma Returns Distribution Density
The distribution of FSD Pharma's historical returns is an attempt to chart the uncertainty of FSD Pharma's future price movements. The chart of the probability distribution of FSD Pharma daily returns describes the distribution of returns around its average expected value. We use FSD Pharma Class price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of FSD Pharma returns is essential to provide solid investment advice for FSD Pharma.
| Mean Return | -0.89 | Value At Risk | -6.82 | Potential Upside | 4.48 | Standard Deviation | 4.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of FSD Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
FSD Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as FSD Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading FSD Pharma Class backward and forwards among themselves. FSD Pharma's institutional investor refers to the entity that pools money to purchase FSD Pharma's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bank Of America Corp | 2023-12-31 | 1.0 | Ground Swell Capital, Llc | 2023-12-31 | 0.0 | Jane Street Group, Llc | 2023-12-31 | 0.0 | Janney Montgomery Scott Llc | 2023-12-31 | 0.0 | The Toronto-dominion Bank | 2023-12-31 | 0.0 | Your Advocates Ltd., Llp | 2023-12-31 | 0.0 | Hrt Financial Llc | 2023-12-31 | 0.0 | Advisorshares Investments, Llc | 2023-12-31 | 270.3 K | Renaissance Technologies Corp | 2023-12-31 | 69.2 K | Scotia Capital Inc | 2023-12-31 | 61.3 K | Ubs Group Ag | 2023-12-31 | 26.4 K |
FSD Pharma Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (721.9K) | (42.6K) | 25.4K | (282.1K) | (324.4K) | (340.7K) | |
| Investments | (306.9K) | 6.5M | 269.0K | 12.1M | (662.1K) | (695.2K) | |
| Change In Cash | (10.1M) | 11.6M | 17.7M | (18.3M) | (14.2M) | (13.5M) | |
| Depreciation | 2.4M | 3.9M | 4.0M | 4.5M | 2.6M | 1.8M | |
| Net Income | (39.8M) | (28.5M) | (33.9M) | (26.7M) | (18.6M) | (19.5M) | |
| Change To Netincome | (3.6M) | 22.4M | 8.0M | 7.6M | 8.7M | 4.8M | |
| End Period Cash Flow | 6.1M | 17.5M | 35.3M | 17.0M | 2.7M | 2.6M | |
| Free Cash Flow | (14.7M) | (19.1M) | (21.2M) | (28.7M) | (11.1M) | (11.6M) | |
| Other Non Cash Items | 716.7K | (672.3K) | 19.6K | (575.1K) | 7.1M | 7.4M |
FSD Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to FSD Pharma or IT Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that FSD Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a FSD stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -1.03 | |
β | Beta against NYSE Composite | 1.59 | |
σ | Overall volatility | 4.19 | |
Ir | Information ratio | -0.23 |
FSD Pharma Volatility Alert
FSD Pharma Class exhibits very low volatility with skewness of 0.92 and kurtosis of 5.09. FSD Pharma Class is a potential penny stock. Although FSD Pharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in FSD Pharma Class. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on FSD instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.FSD Pharma Fundamentals Vs Peers
Comparing FSD Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze FSD Pharma's direct or indirect competition across all of the common fundamentals between FSD Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as FSD Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of FSD Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing FSD Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare FSD Pharma to competition |
| Fundamentals | FSD Pharma | Peer Average |
| Return On Equity | -0.84 | -0.31 |
| Return On Asset | -0.43 | -0.14 |
| Current Valuation | 16.12 M | 16.62 B |
| Shares Outstanding | 40.43 M | 571.82 M |
| Shares Owned By Insiders | 17.36 % | 10.09 % |
| Shares Owned By Institutions | 2.53 % | 39.21 % |
| Number Of Shares Shorted | 333.37 K | 4.71 M |
| Price To Earning | (1.53) X | 28.72 X |
| Price To Book | 1.82 X | 9.51 X |
| Price To Sales | 105.03 X | 11.42 X |
| Gross Profit | (3.33 M) | 27.38 B |
| EBITDA | (17.38 M) | 3.9 B |
| Net Income | (18.56 M) | 570.98 M |
| Cash And Equivalents | 31.62 M | 2.7 B |
| Cash Per Share | 0.83 X | 5.01 X |
| Total Debt | 337.46 K | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 3.98 X | 2.16 X |
| Book Value Per Share | 0.34 X | 1.93 K |
| Cash Flow From Operations | (11.03 M) | 971.22 M |
| Short Ratio | 1.35 X | 4.00 X |
| Earnings Per Share | (0.46) X | 3.12 X |
| Target Price | 6.0 | |
| Beta | 0.91 | -0.15 |
| Market Capitalization | 18.99 M | 19.03 B |
| Total Asset | 17.39 M | 29.47 B |
| Retained Earnings | (157.1 M) | 9.33 B |
| Working Capital | 6.52 M | 1.48 B |
| Current Asset | 3 M | 9.34 B |
| Current Liabilities | 13 M | 7.9 B |
| Net Asset | 17.39 M |
FSD Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as FSD . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About FSD Pharma Buy or Sell Advice
When is the right time to buy or sell FSD Pharma Class? Buying financial instruments such as FSD Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Cash | 35.3M | 17.0M | 2.7M | 2.6M | Accounts Payable | 3.0M | 2.8M | 3.2M | 1.8M |
Use Investing Ideas to Build Portfolios
In addition to having FSD Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Rentals Thematic Idea Now
Rentals
Companies providing rental and leasing services to public and business. The Rentals theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Rentals Theme or any other thematic opportunities.
| View All Next | Launch |
Check out FSD Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for FSD Stock analysis
When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Quarterly Revenue Growth (0.07) | Return On Assets (0.43) | Return On Equity (0.84) |
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.